Trial intelligence / Profile preview

ESWT vs Collagen Hydrolyzed Peptides in Plantar Fasciitis

NCT06138236Phase 1Recruiting

Sponsor
Policlinico di Bari
Start
Jul 2023
Primary completion
Dec 2025
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 1, randomised trial of hydrolysed collagen in plantar fasciitis (3 arms), sponsored by Policlinico di Bari. Primary endpoints: Visual Analog Scale at 30 days and American Foot and Ankle Scale at 60 days. Started Jul 2023; status: recruiting.

02

Drugs

hydrolysed collagen
03

Conditions

plantar fasciitis

Beyond the preview

Go deeper on NCT06138236.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06138236.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call